journal
https://read.qxmd.com/read/39240305/effects-of-mindfulness-based-stress-reduction-training-on-the-negative-emotions-and-social-functioning-of-patients-with-laryngeal-cancer
#1
JOURNAL ARTICLE
Lingxue Yin
OBJECTIVE: To explore the influence of mindfulness-based stress reduction (MBSR) training on the negative emotions and social functioning of patients with laryngeal cancer post-operation. METHODS: Sixty-five patients with laryngeal cancer admitted to our hospital from January 2017 to December 2019 were selected and divided into an observation group of 33 cases and a control group of 32 cases according to the patient's wishes. The control group received routine intervention, while the observation group received mindfulness decompression training in addition to the control group...
September 6, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39240304/in-response-to-letter-to-the-editor-regarding-sbrt-sg-01-final-results-of-a-prospective-multicenter-study-on-stereotactic-body-radiotherapy-for-liver-metastases
#2
LETTER
María-Carmen Rubio Rodríguez, Xin Chen-Zhao
No abstract text is available yet for this article.
September 6, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39240303/tet3-is-expressed-in-prostate-cancer-tumor-associated-macrophages-and-is-associated-with-anti-androgen-resistance
#3
JOURNAL ARTICLE
Qiu-Ju Wei, Hai-Qi Liang, Yao-Wen Liang, Zu-Xin Huang
PURPOSE: The aim of this study is to investigate the expression of TET3 in prostate cancer and its effect on the efficacy of anti-androgen therapy (ADT). METHODS: The expression of TET3 in 1965 cases of prostate cancer and 493 cases of normal prostate tissues were analyzed. The CIBERSORT algorithm evaluated the abundance of 22 tumor-infiltrating immune cells in 497 prostate cancers. Subsequently, the expression of TET3 in prostate cancer TAMs was analyzed using 21,292 cells from single-cell RNA sequencing (scRNAseq)...
September 6, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39240302/lung-immune-prognostic-index-lipi-as-a-prognostic-factor-in-patients-with-extensive-stage-small-cell-lung-cancer-treated-with-first-line-chemoimmunotherapy
#4
JOURNAL ARTICLE
Elena Herranz-Bayo, Luis Enrique Chara-Velarde, Javier Cassinello-Espinosa, Vicente Gimeno-Ballester, Ángel Artal-Cortés, Alba Moratiel-Pellitero, Arancha Alcácera-López, Fátima Navarro-Expósito, Blanca Riesco-Montes, Manuel Clemente-Andujar
INTRODUCTION: The lung immune prognostic index (LIPI) is a biomarker that combines the lactate dehydrogenase (LDH) value and the derived neutrophil/lymphocyte ratio (dNLR). Its prognostic ability has been reported in non-small cell lung cancer (NSCLC) with immunotherapy. In the context of extensive-stage small cell lung cancer (ES-SCLC) with chemoimmunotherapy, its role remains to be determined. METHODS: A retrospective, multicenter study of patients with ES-SCLC who received atezolizumab plus chemotherapy as first-line treatment was conducted...
September 6, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39240301/evaluation-of-immune-checkpoint-molecules-in-dmmr-pmmr-colorectal-cancer-by-multiplex-immunohistochemistry
#5
JOURNAL ARTICLE
Sergei Sergeevich Naumov, Liubov Alexandrovna Tashireva, Nadezhda Valerievna Krakhmal, Sergey Vladimirovich Vtorushin
PURPOSE: Colorectal cancer is the most common malignancy worldwide. A number of pathological and molecular genetic criteria are currently used as predictors of the disease. They include assessment of MMR deficiency or MSI/MSS status, which among others, determine the immunogenicity of the tumor. In this regard, the evaluation of PD-L1, CTLA-4, and LAG-3 immune checkpoint molecules in different tumor compartments according to MMR status deserves special attention. METHODS: Multiplex immunohistochemistry was used to evaluate the expression of immune checkpoint molecules in the tumor core and at the invasive margin...
September 6, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39235556/pcmt1-as-a-prognostic-marker-in-breast-cancer
#6
JOURNAL ARTICLE
Patryk Rogaczewski, Michał Janiak, Jędrzej Borowczak, Łukasz Szylberg
INTRODUCTION: Triple-negative breast cancer (TNBC) is one of the most aggressive cancers in women, therefore it is necessary to determine novel prognostic markers to estimate survival and advancement the treatment of the disease. Recently, PCMT1, a protein mediating TNBC immune infiltration, has gained attention as a potential therapeutic target. The aim of the study was to demonstrate the relationship between PCMT1 protein overexpression as a prognostic indicator for patients with TNBC cancer and patient survival...
September 5, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39235555/prevalence-of-cancer-related-cognitive-impairment-among-patients-with-nasopharyngeal-carcinoma-a-cross-sectional-study
#7
JOURNAL ARTICLE
Suting Song, Qu Hu, Jiayi Du, Sisi Yan, Xuejiao Lei, Ruisi Tang, Chunyu Wang
OBJECTIVE: To examine the prevalence of cancer-related cognitive impairment (CRCI) and its contributing factors in patients with nasopharyngeal carcinoma (NPC) and explore the relationship between various assessment methods. METHODS: A cross-sectional study was conducted with 367 patients with NPC between March 2022 and April 2024 at Chongqing University Cancer Hospital. The data gathered from the demographic questionnaire, Montreal Cognitive Assessment (MoCA), Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog), Self-Rating Anxiety Scale (SAS), and Self-Rating Depression Scale (SDS) were analyzed using logistic regression...
September 5, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39235554/potential-prognostic-biomarker-serpina12-implications-for-hepatocellular-carcinoma
#8
JOURNAL ARTICLE
Huan Yang, Panpan Kong, Songyu Hou, Xiaogang Dong, Imamumaimaitijiang Abula, Dong Yan
BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the most prevalent malignant tumors, exhibiting a high morbidity and mortality rate. The mechanism of its occurrence and development requires further study. The objective of this study was to investigate the role of SERPINA12 in the diagnosis, prognosis prediction and biological function within HCC. METHODS: The Cancer Genome Atlas (TCGA) data were employed to analyze the relationship between clinical features and SERPINA12 expression in HCC...
September 5, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39231914/therapeutic-efficacy-of-rituximab-combined-with-cyclosporin-a-on-b-cell-dysregulation-in-chronic-graft-versus-host-disease
#9
JOURNAL ARTICLE
Xiang-Jun Fu, Can Meng, Li Guo, Li-E Lin
OBJECTIVE: Chronic graft-versus-host disease (cGVHD) is a significant complication following allogenic hematopoietic stem cell transplantation, often necessitating therapeutic interventions such as rituximab (RTX) and cyclosporin A (CsA). This study aims to elucidate the mechanisms by which RTX and CsA jointly address B-cell dysregulation in cGVHD, providing a theoretical foundation and scientific rationale for the treatment and prognostic evaluation of this condition. METHODS: A total of 30 cGVHD mouse models were established by subjecting recipient mice to total body irradiation followed by injection of a mixed suspension of bone marrow cells and splenocytes from donor mice...
September 4, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39230858/stas-new-explorations-and-challenges-for-thoracic-surgeons
#10
REVIEW
Teng Xia, Qian Yuan, Shi-Gui Xing
Spread through air spaces (STAS) represents a relatively novel concept in the pathology of lung cancer, and it specifically refers to the dissemination of tumour cells into the parenchymal air spaces adjacent to the primary tumour. In 2015, the World Health Organization (WHO) classified STAS as a new invasive form of lung adenocarcinoma (LUAD). Many studies investigated the role of STAS and revealed its association with the prognosis of LUAD and its influence on the outcomes of other malignant pulmonary neoplasms...
September 4, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39225960/paediatric-very-rare-tumours-registration-and-management-in-european-countries-with-low-health-expenditure-average-rates
#11
JOURNAL ARTICLE
Jelena Roganovic, Calogero Virgone, Tal Ben-Ami, Yves Reguerre, Andrea Ferrari, Daniel Orbach, Jan Godzinski, Gianni Bisogno, Nuno Jorge Farinha, Malgorzata Krawczyk, Dominik T Schneider, Ines B Brecht, Ewa Bien
PURPOSE: Within the Paediatric Rare Tumours Network-European Registry (PARTNER) project, we aimed to evaluate the situation on the registration and management of paediatric patients affected by very rare tumours (VRT) in the European low health expenditure average rates (LHEAR) countries. METHODS: A survey regarding infrastructure, organisation, and clinical decision-making information on VRT was designed. This survey was distributed to the representatives of LHEAR countries involved in the activities of the PARTNER Work Package 7...
September 3, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39225959/application-of-random-survival-forest-to-establish-a-nomogram-combining-clinlabomics-score-and-clinical-data-for-predicting-brain-metastasis-in-primary-lung-cancer
#12
JOURNAL ARTICLE
Zhongxiang Shi, Yixin Chen, Aoyu Liu, Jingya Zeng, Wanlin Xie, Xin Lin, Yangyang Cheng, Huimin Xu, Jialing Zhou, Shan Gao, Chunyuan Feng, Hongxia Zhang, Yihua Sun
PURPOSE: To establish a nomogram for predicting brain metastasis (BM) in primary lung cancer at 12, 18, and 24 months after initial diagnosis. METHODS: In this study, we included 428 patients who were diagnosed with primary lung cancer at Harbin Medical University Cancer Hospital between January 2020 and January 2022. The endpoint event was BM. The patients were randomly categorized into two groups in a 7:3 ratio: training (n = 299) and validation (n = 129) sets...
September 3, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39225958/hyperprogressive-disease-in-patients-with-advanced-cancer-treated-with-immune-checkpoint-inhibitors
#13
JOURNAL ARTICLE
Gülin Alkan Şen, Nihan Şentürk Öztaş, Ezgi Değerli, Murad Guliyev, Günay Can, Hande Turna, Mustafa Özgüroğlu
BACKGROUND: Hyperprogressive disease (HPD) is a new phenomenon developing in the era of immune checkpoint inhibitor (ICI) therapy. HPD is characterized by an unexpected and fast progression in tumor volume and poor survival. There is no standardized definition for HPD and clinicopathological variables associated with HPD are unclear. Herein, we assessed incidence, treatment outcomes and factors predictive of HPD in patients treated with ICIs. METHODS: We retrospectively analyzed patients with advanced cancer treated with ICI at one academic center between 2014 and 2021...
September 3, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39218812/siraris-survey-of-internal-mammary-radiotherapy-among-radiation-oncologists-from-italy-spain
#14
JOURNAL ARTICLE
A Montero, M Arenas, C Aistei
BACKGROUND: Clinical guidelines for internal mammary chain (IMC) irradiation are not uniformly accepted, with notable differences between countries. This survey examines IMC irradiation practices among radiation oncologists in Italy and Spain. MATERIALS AND METHODS: An online survey was distributed to radiation oncologists via Google Forms. It included 26 questions, 9 on participants' epidemiological data and 17 on IMC irradiation. Participation was voluntary with no financial incentives...
September 1, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39217595/predictive-value-of-prognostic-nutritional-index-as-prognostic-biomarkers-in-patients-with-lymphoma-a-systematic-review-and-meta-analysis
#15
REVIEW
Xuan Liu, Yuqing Duan, Yixian Wang, Xin Zhang, Hongbo Lv, Qiong Li, Na Qiao, Hengyu Meng, Linwei Lan, Xiumin Liu, Xin Liu
BACKGROUND: Several research have indicated the significant potential of the Prognostic Nutritional Index (PNI) as a prognostic biomarker in lymphoma patients. However, there is some inconsistency in the findings of a few studies. Hence, to offer a thorough evaluation of the predictive significance of PNI in lymphoma patients, we performed a meta-analysis to examine the prognostic value of PNI for survival outcomes in lymphoma patients. METHODS: We conducted a comprehensive search for pertinent works published up until December 2023 in databases such as PubMed, EMBASE, Cochrane Library, and Web of Science...
September 1, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39215938/seom-geico-clinical-guidelines-on-cervical-cancer-2023
#16
JOURNAL ARTICLE
Luis Manso, Avinash Ramchandani-Vaswani, Ignacio Romero, Luisa Sánchez-Lorenzo, María José Bermejo-Pérez, Purificación Estévez-García, Lorena Fariña-Madrid, Yolanda García García, Marta Gil-Martin, María Quindós
Cervical cancer (CC) is the fourth most common cancer and the fourth leading cause of mortality in women worldwide. It is strongly associated with high-risk human papillomavirus infection. High-income countries that have implemented human papillomavirus (HPV) vaccination and screening programs have seen dramatic reductions in CC incidence, while developing countries where these programs are not available continue to experience high rates of CC deaths. In early-stage CC, the primary treatment is surgery or radiotherapy, whereas concurrent chemo-radiotherapy (CRT) remains the conventional approach in locally advanced stages until the upcoming approval of immunotherapy...
August 31, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39212912/reply-letter-to-further-insight-into-the-integrating-plasma-proteome-with-genome-reveals-novel-protein-biomarkers-in-colorectal-cancer
#17
LETTER
Changchun Ye, Leizhou Xia, Ruimin Gong, Jingbo Chang, Qi Sun, Jiaxi Xu, Fanni Li
No abstract text is available yet for this article.
August 30, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39212911/slam-family-mediated-crosstalk-between-tumor-and-immune-cells-in-the-tumor-microenvironment-a-promising-biomarker-and-a-potential-therapeutic-target-for-immune-checkpoint-therapies
#18
REVIEW
Louis Boafo Kwantwi
Immune cells infiltrating the tumor microenvironment are physiologically important in controlling cancers. However, emerging studies have shown that cancer cells can evade immune surveillance and establish a balance in which these immune cells support tumor progression and therapeutic resistance. The signaling lymphocytic activation molecule family members have been recognized as mediators of tumor microenvironment interactions, and a promising therapeutic target for cancer immunotherapy. This review is focused on the role of SLAM family in tumor and immune cell interactions and discusses how such crosstalk affects tumor behavior...
August 30, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39212910/clinicopathological-and-prognostic-value-of-tertiary-lymphoid-structures-in-lung-cancer-a-meta-analysis
#19
REVIEW
Luyao Ma, Xiaobing Qin, Aoyang Yu, Haonan Liu, Di Pan, Ying Gao, Zichen Wu, Zihan Chen, Zhengxiang Han
OBJECTIVE: The purpose of this meta-analysis was to examine the clinicopathological and prognostic significance of tertiary lymphocytic infiltrates in lung cancer. METHOD: A systematic search was performed in many databases, including PubMed, Web of Science, Cochrane Library, Embase, CNKI, Wangfangdate, and CBM, up until January 2024. We calculated the hazard ratio (HR), odds ratios (OR), and confidence interval (CI), and accomplished this meta-analysis with Stata 15 software...
August 30, 2024: Clinical & Translational Oncology
https://read.qxmd.com/read/39212909/clinical-significances-of-ttf-1-neuroendocrine-chromogranin-synaptophysin-cd56-and-keratin-pancytokeratin-ck7-ck5-6-marker-immunostaining-in-small-cell-lung-cancer
#20
JOURNAL ARTICLE
Faruk Tas, Akin Ozturk, Kayhan Erturk
PURPOSE: Immunohistochemistry (IHC) markers have established a role in the pathological diagnosis of small cell lung cancer (SCLC) and especially neuroendocrine markers help to differentiate SCLC from other tumors. The study aimed to evaluate the clinical role of different IHC markers in SCLC patients. METHODS: A total of 378 SCLC patients were enrolled in the study and analyzed retrospectively. TTF-1, neuroendocrine markers (chromogranin, synaptophysin, and CD56), and keratin markers (pancytokeratin, CK7 and CK5/6) were assessed...
August 30, 2024: Clinical & Translational Oncology
journal
journal
41053
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.